179 related articles for article (PubMed ID: 35474381)
1. 'I Don't Like Uncertainty, I Like to Know': How and why uveal melanoma patients consent to life expectancy prognostication.
Brown SL; Fisher PL; Morgan A; Davies C; Olabi Y; Hope-Stone L; Heimann H; Hussain R; Cherry MG
Health Expect; 2022 Aug; 25(4):1498-1507. PubMed ID: 35474381
[TBL] [Abstract][Full Text] [Related]
2. Is accurate routine cancer prognostication psychologically harmful? 5-year outcomes of life expectancy prognostication in uveal melanoma survivors.
Brown SL; Fisher P; Hope-Stone L; Damato B; Heimann H; Hussain R; Cherry MG
J Cancer Surviv; 2022 Apr; 16(2):408-420. PubMed ID: 33871760
[TBL] [Abstract][Full Text] [Related]
3. How do patients with uveal melanoma experience and manage uncertainty? A qualitative study.
Hope-Stone L; Brown SL; Heimann H; Damato B; Salmon P
Psychooncology; 2015 Nov; 24(11):1485-91. PubMed ID: 25873360
[TBL] [Abstract][Full Text] [Related]
4. Reconciling the principle of patient autonomy with the practice of informed consent: decision-making about prognostication in uveal melanoma.
Cook SA; Damato B; Marshall E; Salmon P
Health Expect; 2011 Dec; 14(4):383-96. PubMed ID: 21029286
[TBL] [Abstract][Full Text] [Related]
5. Depression, Anxiety, and Regret Before and After Testing to Estimate Uveal Melanoma Prognosis.
Schuermeyer I; Maican A; Sharp R; Bena J; Triozzi PL; Singh AD
JAMA Ophthalmol; 2016 Jan; 134(1):51-6. PubMed ID: 26539659
[TBL] [Abstract][Full Text] [Related]
6. Genetic prognostication in uveal melanoma.
Dogrusöz M; Jager MJ
Acta Ophthalmol; 2018 Jun; 96(4):331-347. PubMed ID: 29105334
[TBL] [Abstract][Full Text] [Related]
7. Psychosocial impact of prognostic genetic testing in uveal melanoma patients: a controlled prospective clinical observational study.
Lieb M; Tagay S; Breidenstein A; Hepp T; Le Guin CHD; Scheel J; Lohmann DR; Bornfeld N; Teufel M; Erim Y
BMC Psychol; 2020 Jan; 8(1):8. PubMed ID: 32005293
[TBL] [Abstract][Full Text] [Related]
8. Psychological aspects of cytogenetic testing of uveal melanoma: preliminary findings and directions for future research.
Cook SA; Damato B; Marshall E; Salmon P
Eye (Lond); 2009 Mar; 23(3):581-5. PubMed ID: 18344957
[TBL] [Abstract][Full Text] [Related]
9. Psychosocial impact of prognostic genetic testing in the care of uveal melanoma patients: protocol of a controlled prospective clinical observational study.
Erim Y; Scheel J; Breidenstein A; Metz CH; Lohmann D; Friederich HC; Tagay S
BMC Cancer; 2016 Jul; 16():408. PubMed ID: 27386847
[TBL] [Abstract][Full Text] [Related]
10. A review of advanced genetic testing for clinical prognostication in uveal melanoma.
Werdich XQ; Jakobiec FA; Singh AD; Kim IK
Semin Ophthalmol; 2013; 28(5-6):361-71. PubMed ID: 24010756
[TBL] [Abstract][Full Text] [Related]
11. A Comprehensive Prognostic and Immunological Analysis of a Six-Gene Signature Associated With Glycolysis and Immune Response in Uveal Melanoma.
Liu J; Lu J; Li W
Front Immunol; 2021; 12():738068. PubMed ID: 34630418
[TBL] [Abstract][Full Text] [Related]
12. Primary Care Practitioners' Views on Incorporating Long-term Prognosis in the Care of Older Adults.
Schoenborn NL; Bowman TL; Cayea D; Pollack CE; Feeser S; Boyd C
JAMA Intern Med; 2016 May; 176(5):671-8. PubMed ID: 27064895
[TBL] [Abstract][Full Text] [Related]
13. Prognostication of metastatic death in uveal melanoma patients: A Markov multi-state model.
Eleuteri A; Taktak AFG; Coupland SE; Heimann H; Kalirai H; Damato B
Comput Biol Med; 2018 Nov; 102():151-156. PubMed ID: 30278339
[TBL] [Abstract][Full Text] [Related]
14. Adding the Cancer Genome Atlas Chromosome Classes to American Joint Committee on Cancer System Offers More Precise Prognostication in Uveal Melanoma.
Gelmi MC; Bas Z; Malkani K; Ganguly A; Shields CL; Jager MJ
Ophthalmology; 2022 Apr; 129(4):431-437. PubMed ID: 34793831
[TBL] [Abstract][Full Text] [Related]
15. [The origin of informed consent].
Mallardi V
Acta Otorhinolaryngol Ital; 2005 Oct; 25(5):312-27. PubMed ID: 16602332
[TBL] [Abstract][Full Text] [Related]
16. Fear of prognosis? How anxiety, coping, and expected burden impact the decision to have cytogenetic assessment in uveal melanoma patients.
Gollrad J; Korpusik N; Rabsahl C; Boehmer D; Besserer A; Grittner U; Boeker A; Keilholz U; Joussen A; Budach V; Goerling U
Support Care Cancer; 2022 Jul; 30(7):5837-5847. PubMed ID: 35355121
[TBL] [Abstract][Full Text] [Related]
17. Digital PCR validates 8q dosage as prognostic tool in uveal melanoma.
Versluis M; de Lange MJ; van Pelt SI; Ruivenkamp CA; Kroes WG; Cao J; Jager MJ; Luyten GP; van der Velden PA
PLoS One; 2015; 10(3):e0116371. PubMed ID: 25764247
[TBL] [Abstract][Full Text] [Related]
18. Primary bilateral uveal melanoma: a population-based study and systematic review.
Scott JF; Vyas R; Galvin J; Gotow E; Fiessinger L; Gerstenblith AT; Gerstenblith MR
Clin Exp Ophthalmol; 2018 Jul; 46(5):502-510. PubMed ID: 29219254
[TBL] [Abstract][Full Text] [Related]
19. The effectiveness of health literacy interventions on the informed consent process of health care users: a systematic review protocol.
Perrenoud B; Velonaki VS; Bodenmann P; Ramelet AS
JBI Database System Rev Implement Rep; 2015 Oct; 13(10):82-94. PubMed ID: 26571285
[TBL] [Abstract][Full Text] [Related]
20. [The effect of sex hormones and pregnancy on development and progression of uveal melanoma].
Likhvantseva VG; Ovanesyan VE
Vestn Oftalmol; 2022; 138(3):110-117. PubMed ID: 35801889
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
